Looks like we will stay between $1.20 and $1.60 till we get some more news!
1. FDA strategy for approval via consultants
2. Any potential licensing/partnerships in key markets (US, Europe, Asia)
3. The launch of our Direct to Consumer teleclinic.
We’ve held up well compared to the entire pharmaceutical/bio space since RFK announcement.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $33.58M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.5¢ | $105.7K | 362.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 407 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |